Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
national top stories
7
×
startups
7
×
life sciences
biotech
boston blog main
boston top stories
deals
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
texas blog main
texas top stories
venture capital
abbvie
biogen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
national
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle top stories
wisconsin blog main
wisconsin top stories
adverum biotechnologies
alzheimer's disease
amgen
astrazeneca
boston
What
ceo
7
×
acquisitions
bio
drug
roundup
biggest
daniel
gilead
medical
medicines
new
o’day
sciences
acquisition
aims
albert
amazon’s
announced
athena
backed
biotech
bourla
build
buy
cancer
cause
chief
circulation
collabs
come
comes
company
company’s
countouriotis
covid
crispr
deal
debut
drugs
dyne’s
Language
unset
unknown
Current search:
startups
×
ceo
×
" national top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play
@xconomy.com
5 years ago
Get Physical: Houston’s Kanthaka Offers Personal Trainers in an Hour